You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 122 No. 6, June 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE 94TH ANNUAL MEETING OF THE WESTERN SURGICAL ASSOCIATION, DEARBORN, MICH, NOV 16-19, 1986-Part II
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (9)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Thyroid Neoplasia Following Radiation Therapy for Hodgkin's Lymphoma

Christopher McHenry, MD; Harriet Jarosz; David Calandra, MD; Anne McCall, MD; A. M. Lawrence, MD, PhD; Edward Paloyan, MD

Arch Surg. 1987;122(6):684-686.


Abstract

• The question of thyroid neoplasia following high-dose radiation treatment to the neck and mediastinum for malignant neoplasms such as Hodgkin's lymphoma in children and young adults has been raised recently. Five patients, 19 to 39 years old, were operated on for thyroid neoplasms that developed following cervical and mediastinal radiation therapy for Hodgkin's lymphoma. Three patients had papillary carcinomas and two had follicular adenomas. The latency period between radiation exposure and the diagnosis of thyroid neoplasm ranged from eight to 16 years. This limited series provided strong support for the recommendation that children and young adults who are to receive high-dose radiation therapy to the head, neck, and mediastinum should receive suppressive doses of thyroxine prior to radiation therapy in order to suppress thyrotropin (thyroid-stimulating hormone) and then be maintained on a regimen of suppression permanently.

(Arch Surg 1987;122:684-686)



Author Affiliations

From the Departments of Surgery (Drs McHenry, Calandra, McCall, and Paloyan, and Ms Jarosz), Medicine (Dr Lawrence), and Biochemistry (Dr Lawrence), Loyola Stritch School of Medicine, Maywood, Ill, and the Research Service, Veterans Administration Hospital, Hines, Ill.


Footnotes

Accepted for publication Jan 16, 1987.

Read before the 94th Annual Meeting of the Western Surgical Association, Dearborn, Mich, Nov 19, 1986.

Reprint requests to Veterans Administration Hospital, PO Box 5, Hines, IL 60141 (Dr Paloyan).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.